Meiwu Technology's 2024 Financial Report: Skincare Expansion & Corporate Restructuring

The financial report from Meiwu Technology Company Limited (File Number: 001-39803) contains several key updates regarding the company's strategic initiatives and corporate actions as of December 2024:
- Business Expansion into Skincare:
- On September 3, 2024, the company incorporated Xiamen Chunshang Health Technology Co., Ltd., a wholly owned subsidiary, to pursue sales of functional skincare products.
- The company has taken steps to acquire trademarks and has signed a sales agreement for RMB 250,000 with a client to sell skincare products manufactured by a third-party manufacturer.
- Material Agreements:
- Termination Agreement: On December 10, 2024, Guogangtong Trading (a subsidiary of Meiwu) entered into a termination agreement with Meiwu Zhishi Technology to terminate previously established contractual arrangements.
- Share Transfer Agreements: On December 24, 2024:
- The company entered into a share transfer agreement with a purchaser to sell all equity interests of Magnum International Holdings Limited for $10, culminating in the purchaser assuming all assets and liabilities of Magnum.
- A similar share transfer agreement was executed for Xinfuxin International Holdings Limited under the same terms as the Magnum agreement.
- Corporate Structure Changes:
- The agreements have resulted in a significant restructuring of the company’s corporate framework, which is illustrated in accompanying diagrams in the report.
- Forward-Looking Statements:
- The report includes forward-looking statements regarding the company’s plans and strategies, indicating that actual results may differ due to various risks and uncertainties.
- Exhibit Index:
- The report includes references to attached exhibits detailing the termination and share transfer agreements.
This report outlines Meiwu's strategic pivot towards the skincare sector, the termination of prior agreements with a variable interest entity (VIE), and the transfer of ownership of two subsidiaries, which may affect its corporate structure and financial performance moving forward.